The Evolving Landscape of T-Cell Redirection in Oncology

A detailed analysis of T-cell redirecting therapies in oncology, comparing the mechanisms of bispecific antibodies and CAR T ...
GEN - Genetic Engineering and Biotechnology News

Novel KIR‑CAR T Approach Shows Early Activity Against Solid Tumors

At AACR, first‑in‑human KIR‑CAR T data show early activity in solid tumors and introduce a novel design aimed at limiting T ...

New KIR-CAR T cell therapy shows promise in multiple solid cancers

CAR, was shown to be safe, with increasing efficacy corresponding to higher doses of the investigational treatment in nine ...
Medscape

Novel CAR T Cells Show Promise for Resistant T-Cell ALL

In a phase 1 study, anti-CD7 chimeric antigen receptor (CAR) T cells induced complete remission in children and adults with relapsed or refractory T-cell acute lymphoblastic leukemia (ALL), with 82% ...
Healio

FDA to ‘carefully shepherd’ CAR T-cell therapy trials in autoimmune, rheumatic disease

The FDA has released a statement saying it will “carefully shepherd” studies to advance the development of chimeric antigen ...